Gastroesophageal Reflux Disease (GERD) Treatment Devices Market is expanding rapidly with Ethicon introducing LINX Reflux Management System to provide effective long-term control over GERD

 

Gastroesophageal reflux disease (GERD) is a type of condition wherein the stomach content moves up from the stomach or esophagus and enters the throat, causing a painful burning sensation. Some common factors that are considered to be the cause of GERD are inappropriate diet, the wrong posture of the body, abnormal eating habits such as fast eating or excessive swallowing, smoking, irregular meal timings, and drinking too much alcohol or coffee. As far as regional impact is concerned, North America seems to be exhibiting a positive outlook with rising incidence of GERD in the region. Besides rapidly growing geriatric population is expected to accelerate the regional Gastroesophageal Reflux Disease (GERD) Treatment Devices Market growth in the near future.

As more individuals are becoming health conscious, the number of Gastroesophageal Reflux Disease (GERD) Treatment Devices offered for sale on the market is increasing. Before making a purchase, the consumer must determine his or her needs and symptoms. It is important that the patient choose devices that are simple to use and do not require many visits to a specialist. A specialist will also be able to recommend the best course of action in dealing with this condition. One of the essential factors governing the demand for GERD treatment devices is the high prevalence of the said diseases across the globe. As per the National Center for Biotechnology Information (NCBI), around 20% of adults in western culture are affected with GERD. According to the same source, the prevalence of GERD in the U.S. was between 18.1% and 27.8% in 2020. Such prevalence of GERD could potentially stimulate growth of the gastroesophageal reflux disease (GERD) treatment devices market.

In adults, excessive secretion of gastric acids or excessive production of saliva leads to the occurrence of gastroesophageal reflux disease (GERD). Most often, GERD develops suddenly and without prior notice. When the condition occurs regularly, it may turn out to be chronic or recurrent and may result in serious complications. However, complications pertaining to gastrointestinal stents implementation remain a major hindrance in the development of the market. Although biodegradable and drug-eluting gastrointestinal stents are being developed, compactions with conventional devices remain prevalent. Such factors can inhibit growth of the gastroesophageal reflux disease (GERD) treatment devices market in the near future.

Of all age groups, elderly people are more likely to develop GERD, followed by pregnant women. In fact, as per Healthline, pregnant women and individuals aged 40 years and above are at higher risk of gastroesophageal disease. As per the World Health Organization (WHO), the global geriatric population is expected to account for around 22% of the global population by 2050. Therefore, these factors can augment growth of the gastroesophageal reflux disease (GERD) treatment devices market. Recently, in November 2020, Ethicon, a subsidiary of Johnson and Johnson Medical Devices Companies, launched LINX Reflux Management System to provide effective long-term control over GERD.

See Full Report@ https://www.coherentmarketinsights.com/ongoing-insight/gastroesophageal-reflux-disease-treatment-devices-market-159